|
1. BIOLOGIE
|
|
|
Cancer cells deactivate their ‘Velcro’ to go on the attack [UC Louvain]
|
|
|
|
|
|
UCLouvain researchers observed that certain cancer cells are, in fact, capable of decreasing the abundance of this ‘Velcro’ (CD166) on their surface. More specifically, these cells have found a way to reduce the adhesion of their surface by redirecting it into small internal vesicles: this is a mechanism called endocytosis.
|
|
|
|
|
|
|
4.16 DÉP., DIAG. & PRONO. - PANCRÉAS
|
|
|
|
5.12.4 IMMUNOTHÉRAPIES - ESSAIS
|
|
|
|
5.12.5 IMMUNOTHÉRAPIES - PHARMA
|
|
|
|
|
|
|
5.2 PHARMA
|
|
|
|
5.5.1 ASCO (GÉNÉRAL)
|
|
|
|
5.5.1.1 ASCO (GÉNÉRAL) - INDUSTRIELS
|
|
|
|
|
|
|
5.5.10 ASCO (HÉMATO)
|
|
|
|
|
5.5.13 ASCO (DIVERS)
|
|
|
|
|
5.5.16 ASCO (MÉDECINE DE PRÉCISION)
|
|
|
|
|
5.5.19 ASCO (REIN)
|
|
|
|
5.5.2 ASCO (SEIN)
|
|
|
|
5.5.3 ASCO (PROSTATE)
|
|
|
|
5.5.4.2 ASCO (IMMUNOTHÉRAPIES-COMBINAISONS)
|
|
|
|
5.5.4.4 ASCO (IMMUNOTHÉRAPIES-POUMON)
|
|
|
|
|
|
|
|
|
|
5.5.4.5 ASCO (IMMUNOTHÉRAPIES-CAR-T, THÉRAPIES CELLULAIRES)
|
|
|
|
|
|
5.5.7 ASCO (GYNÉCO)
|
|
|
|
5.5.8 ASCO (POUMON)
|
|
|
|
|
6.15 LUTTE CONTRE LES CANCERS - COVID-19
|
|
|